Haleon (HLN) Non-Current Debt (2021 - 2026)
Haleon's (HLN) quarterly Non-Current Debt came in at -$8.4 billion in Q2 2026, up 18.97% on a QoQ basis from -$10.4 billion in Q4 2025.
Haleon (HLN) Non-Current Debt (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Non-Current Debt data on file, last reported at -$8.4 billion in Q2 2026.
- Quarterly Non-Current Debt changed N/A year-over-year to -$8.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.4 billion (changed N/A YoY) and the FY2025 annual result came in at -$10.3 billion, down 193.62% from the prior year.
- Non-Current Debt advanced to -$8.4 billion in Q2 2026, from -$10.4 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $11.7 billion in Q4 2022 to a low of -$12.5 billion in Q2 2022.
- A 5-year average of -$2.2 billion and a median of -$8.9 billion in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt surged 9904.36% — and 2025, when it slumped 193.91%.
- Tracing HLN's Non-Current Debt over 5 years: stood at $11.7 billion in 2022, then dropped by 6.91% to $10.9 billion in 2023, then climbed by 1.53% to $11.1 billion in 2024, then tumbled by 193.91% to -$10.4 billion in 2025, then grew by 18.97% to -$8.4 billion in 2026.
- The last three Non-Current Debt figures came in at -$8.4 billion (Q2 2026), -$10.4 billion (Q4 2025), and $11.1 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.44 Bn |
| Dec 31, 2025 | -10.41 Bn |
| Dec 31, 2024 | 11.09 Bn |
| Jun 30, 2024 | -9.35 Bn |
| Dec 31, 2023 | 10.92 Bn |
| Jun 30, 2023 | -10.97 Bn |
| Dec 31, 2022 | 11.73 Bn |
| Jun 30, 2022 | -12.49 Bn |
| Dec 31, 2021 | 117.28 Mn |